Contents to volume xxi

Contents to volume xxi

Progress CARDIOVASCULAR in DISEASES EDMUND H. SONNENBLICK, M.D., Editor MICHAEL LESCH, M.D., Co-Editor Charles K. Friedberg, M.D., Founding Editor ...

129KB Sizes 3 Downloads 63 Views

Progress CARDIOVASCULAR

in DISEASES

EDMUND H. SONNENBLICK, M.D., Editor MICHAEL LESCH, M.D., Co-Editor Charles K. Friedberg, M.D., Founding Editor

VOLUME

XXI,

1978-1979

No. 1 (July/August) ECHOCARDIOGRAPHY. Echocardiography for the Evaluation and Atrium.........................................

of the Tricuspid

III.

Valve, Right Ventricle,

Masapuki

Matsumoto

Ultrasonic Assessmentof Transposition of the Great Vessels .

Special

.

Matsuo

I

. RaJwzond Grarniak and Navin C. Nanda

43

and Hirohide

A rticle

Natural History of Obstructive Coronary Artery Disease: Ten-Year Study of 60 I Nonsurgical Cases.. . .. . . . .. . . .. . . . .. . . . .. . . William L. Proudjt, Albert V. G. Bruschke, and F. Mason

Sones. Jr.

53

W. Baker

79

and C. M. Ouklej-

92

No. 2 (September/October) ECHOCARDIOGRAPHY.

IV.

The Present Role of Doppler Techniques in Cardiac Diagnosis.. . Echocardiographic Evaluation of the Mitral Valve . .

.

,.

..

. R. B. Pridie

. Donald

The Use of Echocardiography for Quantitative Evaluation of Left Ventricular Function Steven J. Mason

Echocardiographic Evaluation of Pericardial Diseases . . . Special

.

.

and Nicholas . .Louis

J. Fortuin

Evan Teichholz

1 19 I 33

Article

Clinical Pharmacokinetics of Digitalis Glycosides.. . . . . . . . .James E. Doherty, James J. Kane, Joe K. Bissett,

and Marvin

N. de So~~za, L. Murphy

141

No. 3 (November/December) CAPTOPRIL The Renin System in High Blood Pressure, From Disbelief to Reality: Converting-Enqme Blockade for Analysis and Treatment . . . . . .John H. Laragh Physiologic,

Biochemical,

and Immunologic

Design of New Antihypertensive Converting Enzyme . ..

Aspects of Angiotensin-Converting Enzyme Richard L. Sqfer and Edmund H. Sonnenhlick

Drugs: Potent and Specific Inhibitors of AngiotensinDavid W. Cushman. Hong Son Cheung, Emil)! F. Saho, and Miguel ,4. Ondetti

I59 167

176

Captopril (SQ 14,225) (D-3-Mercapto-2-Methylpropanoyl-[.-Proline): A Novel Orally Active Inhibitor of Angiotensin-Converting Enzyme and Antihypertensive Agent Bernard Rubin. Michael J. Antonaccio. and Zola P. Horowitz

1x3

Clinical Experience With Blockade of the Renin-Angiotensin-Aldosterone System by an Oral Converting-Enzyme Inhibitor (SQ 14,225, Captopril) in Hypertensive Patients David B. Case. Steven A. Atlas, John H. Laragh. Jean E. Sealql~. Patric,ia .4. Sullivun. and Doris N. McKin.qtr,~

195

Special Article Ultrastructural

Features of Hypertrophied

Human Ventricular Myocardium Barr,, J. Maron and Victor J. Ferran.c

207

No. 4 (January/February) FIBRINOLYSIS.

Symposium

on Fibrinolysis:

The Fibrinolytic

System-Basic

The Role of the Fibrinolytic Natural

Inhibitors

Introduction Considerations

.

I.

HUM C. Kbaan

239

. . Francis J. Castellino and Bernard N. Violand

24 l

. _,

System in Thromboembolism

_.

. . . Joseph G. Vermylen and Dalton A. F. Chamone

255

Nobuo Aoki

267

Against Ventricular Fibrillation in Acute Myocardial Infarction Hillel S. Ribner. Ellen S. Isaacs, and William H. Frishman

287

of Fibrinolysis

.

. . . . . . . . . . . .._........................................

Special Article Lidocaine

Prophylaxis

No. 5 (March/April) FIBRINOLYSIS. Pharmacology

of Fibrinolytic

Guidelines for Thrombolytic

Agents..

..................................................................

Therapy of Deep-Vein Thrombosis

Thrombolytic

Therapy of Pulmonary

Thromboembolism

Thrombolytic

Therapy in Myocardial

Infarction..

Thrombolytic

Therapy in Arterial

Synthetic

Fibrinolytic

Fibrinolysis-A

II. H. Barlow

3 15

Victor J. Marder

327

Grant

........................

......................................

Edward

..........................................................

Thromboembolism

333

F. Duckert

342

M. Martin of H. Auel)

35 1

John F. Davidson and lsobel D. Walker

375

.................................................... (with the technical supervision

Agents.. .........................................

Genton

Perspective ......................................................................................

Hau C. Ktilaan

397

No. 6 (May/June) SPECIAL Prostaglandins, Their Intermediates Roles in Normal and Abnormal

ARTICLES

and Precursors: Cardiovascular Actions and Regulatory Circulatory Systems . .. .. .. ... ..._......._......... Gregor]* J. Dusting, Salvador Moncada, and John R. Vane

405

and Predictive Capacity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. H. Ellestad, Bernard M. Cooke, Jr., and Paul S. Greenberg

43 1

Infarction .. .. .. .. ... .. .. .. ... .. . ... .. Arthur C. For. Ephraim Classman. and 0. Wayne Isom

461

Annual Indexes .. .. .. ... .. .. .. ... . .. ... .. .. .. ... .. .. .. .. .. ... .. . ... .. .. .. ... .. .. .. .. ... .. .. .. .. ... .. .. .. ... . ... .. .. .. .. ... .. .. .. .. ... .. ..........

485

Stress Testing: Clinical Application Surgically

Remediable Complications

of Myocardial